Prion proteins can adopt multiple infectious strain conformations. Here we investigate how the sequence of a prion protein affects its capacity to propagate specific conformations by exploiting our ability to create two distinct infectious conformations of the yeast [PSI + ] prion protein Sup35, termed Sc4 and Sc37. PNM2, a G58D point mutant of Sup35 that was originally identified for its dominant interference with prion propagation, leads to rapid, recessive loss of Sc4 but does not interfere with propagation of Sc37. PNM2 destabilizes the amyloid core of Sc37 and causes compensatory effects that slow prion growth but aid prion division and result in robust propagation of Sc37. By contrast, PNM2 does not affect the structure or chaperone-mediated division of Sc4 but interferes with its delivery to daughter cells. Thus, effective delivery of infectious particles during cell division is a crucial and conformation-dependent step in prion inheritance.
a r t i c l e s Infectious proteins, or prions, are a form of conformation-based inheritance in which a prion protein aggregate binds to and catalyzes the conversion of newly made proteins to the prion form, thereby creating stably propagating states 1 . Such conformation-based inheritance underlies a range of transmissible spongiform encephalopathies in mammals as well as heritable epigenetic states in fungi, of which the yeast Saccharomyces cerevisiae prion [PSI + ] is arguably the best characterized 2 . A common feature of prion proteins is that they misfold into ordered, β-sheet-rich amyloid fibers whose self-templating nature is thought to form the basis of prion propagation 1, 3 . A single prion protein can adopt a spectrum of amyloid conformations that lead to different, heritable strain variants [4] [5] [6] [7] [8] [9] [10] [11] .
The yeast prion [PSI + ], which results from the aggregation of the translation termination factor Sup35, has emerged as a powerful system for studying strain variants. Sup35 can form different amyloid conformations in vitro when polymerized at 4 °C or at 37 °C (refs. 8, 12, 13) . When introduced into yeast, these amyloid fibers form two distinct strains in vivo termed [PSI + ] Sc4 and [PSI + ] Sc37 , respectively. (For clarity, we use [PSI + ] Sc4 to describe the in vivo strain and Sc4 to describe the fiber conformation.) These strains are distinguished by the degree of Sup35 aggregation: [PSI + ] Sc4 yeast show a strong prion phenotype, in which the large majority of Sup35 is aggregated, whereas [PSI + ] Sc37 yeast have a larger pool of soluble Sup35 and a weaker prion phenotype. Structural studies have shown that there is a marked expansion of the amyloid core in the Sc37 conformation relative to that found in Sc4 (refs. 14, 15) . The more extensive structure in Sc37 fibers increases fiber stability and decreases the rate of prion replication by the cell's chaperone system, which results in the weaker [PSI + ] Sc37 prion phenotype 16 . The ability to probe the biophysical properties of these defined strain variant conformations in vitro and to monitor their phenotypes in vivo makes [PSI + ] an excellent system for the study of prion strain phenomena.
The precise amino acid sequence greatly biases the ability of a prion protein to adopt particular strain variants 7, [17] [18] [19] . For example, the naturally occurring methionine-valine polymorphism at position 129 of the mammalian prion protein strongly influences disease susceptibility 20 . The Val129 allele does not interfere with the propagation of all prion strain variants and may even favor some, including certain iatrogenic forms of Creutzfeldt-Jakob disease 19 . However, the presence of even a single allele of Val129 seems to be highly protective against new variant Creutzfeldt-Jakob disease (nvCJD) 21 , which is thought to result from the transmission of bovine spongiform encephalopathy (mad cow disease) to humans 22, 23 .
This strong relationship between strain variants and the sequence of the prion protein extends to the [PSI + ] prion system. A mutant of the Sup35 prion protein, which was originally identified in a screen for 'Psi no more' mutants that prevented propagation of [PSI + ], shows strain variant-specific effects. This mutant, termed PNM2, has a glycine-to-aspartate missense mutation at residue 58 (ref. 24) . Originally, the effect of PNM2 was described as causing dominant inhibition of prion propagation when co-expressed with wild-type Sup35 (refs. 24,25) . Later studies found that PNM2 does not interfere with the propagation of all [PSI + ] strain variants and might enhance the propagation of certain strain variants when overexpressed 17 .
Here we used the PNM2 mutant and the well-defined prion strain conformations Sc4 and Sc37, together with in-depth biophysical and a r t i c l e s in vivo analyses, to investigate how point mutations can affect prion propagation in a manner that depends on the strain variant. Our systematic characterization of fiber structure, chaperone-mediated division of fibers into seeds and delivery of seeds to daughter cells revealed a PNM2-specific defect in seed partitioning for the [PSI + ] Sc4 strain variant. The findings indicate that the delivery of fiber seeds to daughter buds is a key step in prion propagation.
RESULTS

PNM2 shows strain-specific effects on [PSI + ] propagation
We began by characterizing the effect of the PNM2 mutation on prion propagation in [PSI + ] Sc4 and [PSI + ] Sc37 yeast. To allow rapid exchange of alleles, we used a yeast background in which the genomic copy of SUP35 was deleted and replaced by a copy on a plasmid containing the counter-selectable URA3 marker. We exchanged this plasmid with one that encoded wild-type Sup35 (WT) or Sup35 G58D (PNM2) and confirmed that the two proteins were expressed at similar levels ( Fig. 1a) . We assessed the prion phenotype with a red-white color readout that results from suppression of a nonsense mutation in an ADE1 reporter (the ade1-14 allele) 26 ; Fig. 1b ). This assay also indicates the stability of prion inheritance: when a cell in a growing colony loses [PSI + ], its progeny remain prion-free and form a red sector ( Fig. 1c) .
Using the [PSI + ] Sc4 and [PSI + ] Sc37 yeast backgrounds, we found that PNM2 has marked, strain variant-specific effects on prion propagation. When expressed as the sole copy of Sup35, PNM2 strongly compromised the propagation of [PSI + ] Sc4 , apparently by the continuous generation of prion-free ([psi − ]) states ( Fig. 1b-d) . This effect is similar to the originally reported description of the PNM2 phenotype 24, 25 , although there are differences between studies: PNM2 is recessive in our strain background and thus does not strongly interfere with the propagation of [PSI + ] Sc4 when co-expressed with the wild type ( Fig. 1b) . Thus, we focused on analyzing effects of prion propagation when PNM2 is expressed as the sole copy of Sup35.
In contrast to its marked effect on the propagation of [PSI + ] Sc4 , PNM2 had a much weaker effect on propagation of the [PSI + ] Sc37 strain variant, with at most a mild darkening of the color phenotype and no discernable increase in prion loss ( Fig. 1b,d) . This result was unexpected because previous studies indicated that the PNM2 mutation was located in a region that is structured in Sc37 but not in Sc4 (ref. 15 ), leading us to expect that the PNM2 mutation would preferentially interfere with propagation of the Sc37 conformation.
We first investigated whether the defect in stable inheritance seen in [PSI + ] Sc4 yeast could arise from the PNM2 mutation forcing an irreversible structural change that results in an amyloid conformation that is poorly propagated. We carried out a series of plasmid exchanges, replacing the wild-type plasmid with the PNM2 plasmid and then exchanging it back with the wild-type plasmid. Reintroduction of the wild-type plasmid fully restored the original [PSI + ] Sc4 phenotype (Fig. 1e) , indicating that the PNM2 Sc4 fibers retained the structural information necessary to template wild-type Sup35 to the characteristic Sc4 amyloid conformation.
To investigate what accounts for the negative impact of PNM2 on the propagation of [PSI + ] Sc4 but not of [PSI + ] Sc37 , we systematically tested the parameters that affect each step in the prion replication cycle ( Fig. 2) : fiber growth; fiber division, of which fiber stability and ability to interact with the in vivo chaperone prion-replication machinery are key determinants; and the delivery of prion particles to daughter cells during cell division.
PNM2 disrupts Sc37 growth rate and structural stability
To determine whether changes in fiber growth rates account for the observed phenotypic differences, we compared the in vitro growth rates of wild-type and PNM2 fibers. Although earlier studies found that PNM2 fibers have a partial growth defect, the nature of the prion strain variants in these studies was not well defined 27 . We used a fragment of Sup35 (SupNM; residues 1-254, containing the Q/N-rich N-terminal and highly charged middle domains of Sup35) that is necessary and sufficient to support prion propagation 28, 29 . We monitored the seeded polymerization rates of soluble SupNM by measuring the increase in fluorescence intensity of Thioflavin T. When seeded, a r t i c l e s PNM2 SupNM polymerized into the Sc37 conformation more slowly than did wild-type SupNM (Fig. 3 ). As this change in growth rate would be predicted to weaken the prion phenotype, other mechanisms must account for the similar phenotype of PNM2 and wild-type Sup35 in the Sc37 conformation. A PNM2-induced change in amyloid structure could explain the change in Sc37 fiber growth rate as well as provide insight into prion division rates in vivo 16 . Therefore, we used a range of biophysical techniques, including hydrogen/deuterium (H/D) exchange NMR, fiber thermal denaturation and propensity for shearing to produce new fiber seeds, to analyze the structure and stability of PNM2 SupNM fibers. We measured shearing efficacy by the ability of long fibers fragmented by stirring to seed monomer growth as measured from the initial polymerization rates of such reactions.
For the H/D exchange experiments, we monitored the extent of backbone amide exchange for both wild-type and PNM2 fibers at two different time points: after a short exchange period of 2 min and after a more extensive exchange period of 1 day. Based on previous assignments 15 , we measured exchange for 132 residues including extensive probes throughout the amyloid core of both the Sc4 and Sc37 conformations.
The H/D exchange experiments revealed that the PNM2 mutation induced specific, localized structural defects in the Sc37 conformation. Specifically, we observed a region of increased exchange in residues proximal to the site of the PNM2 mutation for both early and late exchange time points ( Fig. 4a,b) . Consistent with this result, we observed a decrease in the thermal stability of PNM2 SupNM Sc37 fibers (T m = 80 ± 2 °C) compared to wild-type SupNM Sc37 fibers (T m = 86 ± 2 °C; Fig. 3c,d) . In addition, when subjected to shearing forces, PNM2 SupNM Sc37 fibers fragmented more than wild-type SupNM Sc37 fibers (Fig. 3e) . These results suggest that the PNM2 mutation in the Sc37 conformation causes a localized structural destabilization with a resulting decrease in fiber stability.
The effects of the PNM2 mutation on Sc37 fibers may have opposing consequences for prion propagation. The localized structural defect would be expected to enhance the rate of prion division in vivo, increasing the rate of generation of free fiber ends and subsequently strengthening the prion phenotype 15, 16 . By contrast, the decrease in fiber growth would be expected to reduce monomer addition onto fibers and therefore to weaken the prion phenotype. Therefore, we hypothesize that the modest overall effect of the PNM2 mutation on the [PSI + ] Sc37 phenotype is the result of compensatory changes.
PNM2 does not affect growth, stability or structure of Sc4
To determine the mechanism by which the PNM2 mutation interferes with the propagation of [PSI + ] Sc4 , we carried out a set of experiments on Sc4 fibers analogous to those done on the Sc37 conformation. When seeded by Sc4, PNM2 SupNM polymerized into the Sc4 conformation at a rate similar to wild-type SupNM, which indicates that the negative effect of the PNM2 mutation on [PSI + ] Sc4 propagation cannot be explained by a decrease in fiber growth rate ( Fig. 3a,b) . The Sc4 fiber structure was also unaffected by the PNM2 mutation: H/D exchange experiments showed no appreciable differences between wild-type SupNM and PNM2 SupNM fibers in the Sc4 conformation ( Fig. 4c,d) . Both the regions of protection and the extent of protection for all residues were virtually indistinguishable between the two samples for both short and long exchange times, suggesting that the structures were stable as well as very similar. Consistent with the above results, the melting temperatures of wild-type SupNM and PNM2 SupNM in the Sc4 conformation were comparable (77 ± 2 °C and 77 ± 5 °C, respectively; Fig. 3c,d) . Last, when subjected to shearing forces, both PNM2 SupNM and wild-type SupNM fragmented to a similar extent ( Fig. 3e) .
Together, these results indicate that PNM2 SupNM can polymerize into fibers with growth, structure and stability that are indistinguishable from those of wild-type Sc4 fibers, and that the defect in [PSI + ] Sc4 propagation cannot be explained by the biophysical properties of the fibers.
PNM2 does not affect Sc4-chaperone interactions
Prion propagation depends crucially on the host chaperone machinery, and in particular on Hsp104 (ref. 26 ). There is growing evidence that Hsp104 acts with Ssa1 (Hsp70) and Sis1 (Hsp40) to divide prion particles and thereby to facilitate prion replication [30] [31] [32] [33] . Specifically, Ssa1 and Sis1 bind to prion particles and deliver them to Hsp104, which is thought to extract prion particles from fibers in an ATP-dependent process that involves translocation of the extracted monomers through its axial pore 34 . In addition to its role in propagation, when expressed at high levels Hsp104 also causes curing of the prion (conversion from [PSI + ] to [psi − ]) through a mechanism that is separate from fiber division. Therefore, the overall effect of Hsp104 is a balance between the fiber division that is necessary for propagation at low levels and a r t i c l e s curing at high levels 26 . As a fiber's differential susceptibility to fragmentation and curing by Hsp104 can directly affect its propagation, we investigated whether changes in chaperone-prion interactions caused the PNM2 phenotype. One possible explanation for the ability of the PNM2 mutation to interfere with [PSI + ] Sc4 propagation is that it causes loss of [PSI + ] through increased susceptibility to curing by Hsp104. To explore this possibility, we used a truncated variant of Hsp104 that is missing its N-terminal domain, termed Hsp104∆NTD (ref. 35) . When this variant is expressed from the endogenous HSP104 locus in the genome, it is fully active in [PSI + ] propagation and can mediate thermotolerance but does not cure [PSI + ] when overexpressed 35 (Supplementary Fig. 1a) . We found the defect in [PSI + ] propagation in PNM2 even in the strain expressing Hsp104∆NTD, which established that the sectoring seen in PNM2 was not due to curing by the mechanism that occurs when Hsp104 is overexpressed (Fig. 5a) .
An alternate hypothesis is that the PNM2 mutation causes increased susceptibility to the fiber division activity of Hsp104 and that this leads to resolubilization of fibers. To test this, we expressed HSP104 and hsp104∆NTD from a low-copy (CEN/ARS) plasmid that leads to a 2-3-fold increase in expression. At this level of expression, wild-type Hsp104 destabilized [PSI + ] whereas Hsp104∆NTD did not (Fig. 5b) , which indicates that the destabilization must be due to the curing activity of Hsp104 and not to overfragmentation. Overexpression of Hsp104∆NTD did not enhance PNM2 sectoring, which supports the idea that PNM2 fibers are not overly susceptible to fragmentation and resolubilization by Hsp104 ( Fig. 5b and Supplementary  Fig. 1b) . These results are distinct from those of others 36 , who found that the PNM2 mutation can lead to fiber destabilization and enhanced Hsp104-mediated fiber dissolution. The differences between the two studies probably result from differences in the prion strain conformations that were examined; previous studies 36 found dominant curing of [PSI + ] when wild-type and PNM2 Sup35 were co-expressed whereas we found that the PNM2 phenotype was recessive in Sc4. In addition, the fact that the PNM2 mutation destabilized the fibers, as reported in ref. 36 suggests that residue 58 is within the amyloid core of their strain conformation. We have generated examples of prion strain conformation that, like the Sc4 conformation, lead to 'strong' prion phenotypes but nonetheless have amyloid cores that extend across residue 58 (unpublished data).
In an independent assay of Hsp104 activity, we used semi-denaturing detergent-agarose gel electrophoresis (SDD-AGE) to look at the size distribution of prion fibers. Changes in Hsp104 activity affect aggregate size 37 and Sc37 fibers, which are severed less efficiently by Hsp104 in vivo, are larger than those in the Sc4 conformation 16 . We examined the relative sizes of Sc37 and Sc4 fibers and found that PNM2 and wild-type Sc4 fibers have the same size distribution (Fig. 5c) . This finding is consistent with our Hsp104∆NTD data and indicates that PNM2 and wild-type Sc4 interact equally with Hsp104.
Finally, to look more directly at interactions between Hsp104 and Sc4 fibers, we used a system developed to monitor the flux of substrates through the axial pore of Hsp104 (Fig. 5d) . The system uses derivatives of Hsp104 (HAP 34 and 4BAP 33 ) engineered to interact with ClpP, a bacterial protein that forms a proteolytic chamber. When used in conjunction with a catalytically dead mutant of ClpP (ClpP trap ), Gly7
Ala34 Tyr35 Asn36 Ala37 Gln15 Asn9 a r t i c l e s substrates of Hsp104 are translocated through HAP and trapped in the ClpP chamber. Thus, after inducing ClpP trap in HAP-expressing yeast, we affinity purified ClpP trap to identify Hsp104 substrates. Given that translocation through Hsp104 is likely to be the terminal event in an interaction between Sup35 and the chaperone machinery, defects in any aspect of this interaction would be expected to yield changes in the flux of Sup35 through Hsp104. Previous studies have shown that Sup35 is delivered to ClpP trap in a HAP-dependent manner and that HAP translocates Sup35 into ClpP trap only in [PSI + ] cells 33, 34 . Moreover, substantially less Sup35 is trapped in the weak [PSI + ] Sc37 strain than in the strong and more efficiently divided 16 [PSI + ] Sc4 strain 33 . We confirmed that wild-type Sup35 was trapped in a [PSI + ]-dependent manner (Fig. 5e) and found that the flux of PNM2 through Hsp104 was similar to that of the wild type when PNM2 was either expressed as the sole source of Sup35 or coexpressed with the wild type ( Fig. 5f,g) . Therefore, consistent with our Hsp104∆NTD and SDD-AGE data, the HAP-ClpP trap system shows that PNM2 Sc4 fibers interact normally with the Hsp104 chaperone machinery that is necessary for propagation.
PNM2 causes a defect in Sc4 propagon partitioning
We investigated whether the PNM2 mutation caused a defect in the delivery of [PSI + ] Sc4 infectious particles (propagons) to daughter cells during cell division using a published method 38 . Briefly, we separated corresponding pairs of mother and daughter cells and grew them in medium containing guanidine, which reversibly inhibits Hsp104 (refs. [39] [40] [41] , so that the number of propagons remained fixed. As the cells divided, a point was reached at which there was no more than one propagon per cell. When we restored Hsp104 function by removing guanidine, the number of [PSI + ] colonies that arose from the mother versus the daughter reported on the relative number of propagons in each mother-daughter pair. Although this assay does not yield a quantitative measure of the absolute number of prion particles, it allows relative propagon numbers and loss of [PSI + ] by one of the partners to be monitored.
Using the above assay for [PSI + ] Sc4 cells expressing wild-type or PNM2 Sup35, we found evidence of partitioning dysregulation in PNM2 [PSI + ] Sc4 cells (Fig. 6a,b) . The mild bias in the distribution of propagons toward the mother and positive correlation between the number of propagons in the mother and daughter wild-type [PSI + ] Sc4 cells seen previously 38, 42 were lost in PNM2 [PSI + ] Sc4 cells. For a subset of pairs, the mother contained a large number of propagons but the daughter did not inherit any. By contrast, we did not observe any pairs in which the daughter had propagons but the mother did not. The failure of propagons to partition into daughter cells accounts for the rapid appearance of red [psi − ] sectors in PNM2 [PSI + ] Sc4 yeast colonies. Previous studies indicate that the mother bias in the allocation of [PSI + ] particles is roughly consistent with differences in cell volume between the mother and the daughter, suggestive of partitioning by passive diffusion 42 . Other studies point to the potential for more active mechanisms in the segregation of protein aggregates, including the active recruitment of cytosolic aggregates to specific loci 43, 44 . Because the PNM2 mutation lies outside the amyloid core of the Sc4 conformation, it could disrupt interactions between this region of the prion protein and host factors that are responsible for prion segregation.
Evidence that host factors have a role in the partitioning of prion particles came from an unbiased genetic screen for high-copy suppressors of the PNM2 phenotype, in which we identified multiple independent isolates of two genes, LSB3 and ART5, that when overexpressed minimized sectoring in PNM2 [PSI + ] Sc4 yeast ( Supplementary  Fig. 2a,b and Supplementary Methods). Lsb3 interacts with Las17 and the Sla1-End3-Pan1 complex, both of which are involved in the regulation of actin dynamics [45] [46] [47] . The actin cytoskeleton has been implicated in both transport of general protein aggregates between mother and daughter cells 43 and the regulation of prion formation 48, 49 . Art5 is primarily uncharacterized but has been proposed to be active in the regulation of endocytosis 50, 51 . Although full characterization of the role of these proteins in prion biology is beyond the scope of this study, it will be interesting to determine how prion particles are affected by actin-based transport and whether endocytic pathways are involved in prion delivery to daughter cells.
Recent studies have suggested that size selection has a vital role in the transmission of prion particles to daughter cells 52 . In this size-based model, the small prion particles, which are preferentially propagated to daughter cells, might be the species that are primarily affected by the PNM2 mutation; these transmission-competent particles are either not delivered to daughter buds or actively retained in the mother cell. These possibilities may be related to the more general mechanism in which the cell specifically recognizes and concentrates misfolded protein aggregates 43, 44 . In the future, an understanding of the relationship between the cellular machinery for segregation of general protein aggregates and prion transmission is essential.
Our studies illustrate the importance of the delivery of infectious proteins to daughter cells in the propagation cycle of [PSI + ]. In the future, we anticipate that the [PSI + ] system will be useful for studying how cells survey, partition and sequester protein aggregates. The PNM2 mutation in the Sc4 conformation should provide a key tool for such studies, as it shows a distinct partitioning defect that is not confounded by changes in amyloid structure or chaperone-mediated fiber division.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
